GENIX PHARMACEUTICALS CORPORATIONGENIX PHARMACEUTICALS CORPORATIONGENIX PHARMACEUTICALS CORPORATION

GENIX PHARMACEUTICALS CORPORATION

No trades
See on Supercharts
Market capitalization
‪3.55 M‬CAD
−0.070CAD
‪−4.40 M‬CAD
‪12.35 K‬CAD
‪33.40 M‬
Beta (1Y)
1.32

About GENIX PHARMACEUTICALS CORPORATION

CEO
Sina Salehi Pirooz
Headquarters
Vancouver
Founded
1993
ISIN
CA37232A1093
FIGI
BBG000BBGH16
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company was founded on July 12, 1993 and is headquartered in Vancouver, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GENX is 0.055 CAD — it has decreased by 8.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange GENIX PHARMACEUTICALS CORPORATION stocks are traded under the ticker GENX.
GENX stock is 9.09% volatile and has beta coefficient of 1.32. Check out the list of the most volatile stocks — is GENIX PHARMACEUTICALS CORPORATION there?
Yes, you can track GENIX PHARMACEUTICALS CORPORATION financials in yearly and quarterly reports right on TradingView.
GENX stock has fallen by 26.67% compared to the previous week, the last month showed zero change in price, over the last year GENIX PHARMACEUTICALS CORPORATION has showed a 10.00% increase.
GENX net income for the last quarter is ‪−59.06 K‬ CAD, while the quarter before that showed ‪−3.77 M‬ CAD of net income which accounts for 98.43% change. Track more GENIX PHARMACEUTICALS CORPORATION financial stats to get the full picture.
Today GENIX PHARMACEUTICALS CORPORATION has the market capitalization of ‪3.26 M‬, it has decreased by 9.33% over the last week.
No, GENX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GENX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENIX PHARMACEUTICALS CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
GENX reached its all-time high on Nov 9, 1998 with the price of 1.050 CAD, and its all-time low was 0.005 CAD and was reached on Sep 20, 2005.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENIX PHARMACEUTICALS CORPORATION technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENIX PHARMACEUTICALS CORPORATION stock shows the sell signal. See more of GENIX PHARMACEUTICALS CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENIX PHARMACEUTICALS CORPORATION EBITDA is ‪−291.90 K‬ CAD, and current EBITDA margin is ‪−2.70 K‬%. See more stats in GENIX PHARMACEUTICALS CORPORATION financial statements.